CPBTD
ALNY icon

Central Pacific Bank - Trust Division’s Alnylam Pharmaceuticals ALNY Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$127K Hold
515
– – 0.01% 544
2026
Q2 		$155K Sell
515
-1,898
-79% -$572K 0.02% 532
2026
Q1 		$798K Hold
2,413
– – 0.1% 205
2025
Q4 		$960K Sell
2,413
-222
-8% -$98.2K 0.12% 182
2025
Q3 		$1.2M Sell
2,635
-383
-13% -$156K 0.15% 150
2025
Q2 		$984K Buy
3,018
+365
+14% +$101K 0.13% 169
2025
Q1 		$716K Buy
2,653
+1,648
+164% +$424K 0.1% 204
2024
Q4 		$236K Sell
1,005
-20
-2% -$5.26K 0.03% 417
2024
Q3 		$282K Sell
1,025
-25
-2% -$6.51K 0.04% 398
2024
Q2 		$255K Hold
1,050
– – 0.03% 487
2024
Q1 		$161K Buy
+1,050
New +$175K 0.02% 594

Other funds holding ALNY

MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
LJHT
Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
BFS
Burkett Financial Services Rock Hill, South Carolina $331M AUM 14.93% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Central Pacific Bank - Trust Division's ALNY Position: Q3 2026 in Review

Central Pacific Bank - Trust Division held its Alnylam Pharmaceuticals (ALNY) position steady in Q3 2026 at 515 shares worth $127K. The position accounts for 0.01% of the portfolio, ranked #544.

Central Pacific Bank - Trust Division first reported a position in ALNY in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.2M in Q3 2025. 19 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • Central Pacific Bank - Trust Division held 515 shares of Alnylam Pharmaceuticals worth $127K as of Q3 2026.
  • Central Pacific Bank - Trust Division left its Alnylam Pharmaceuticals share count unchanged in Q3 2026.
  • Alnylam Pharmaceuticals made up 0.01% of Central Pacific Bank - Trust Division's portfolio in Q3 2026, its #544 holding.
  • Central Pacific Bank - Trust Division first reported a position in Alnylam Pharmaceuticals in Q1 2024 and has held it in 11 quarters since.
  • Central Pacific Bank - Trust Division's Alnylam Pharmaceuticals position peaked at $1.2M in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.